Two recent studies 11, 24, despite only including patients with PDD and PD (and not DLB), are perhaps the most informative, highlighting the possible importance of cortical Aβ and phosphorylated tau (phosphotau) in the rate of decline into dementia. The gene discussed is MAPT; the disease is Parkinson disease.